Arrowhead Pharmaceuticals Inc.

NASDAQ:ARWR   10:06:17 AM EDT
28.36
-0.34 (-1.18%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.51B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$41.97 Million
Adjusted EPS-$0.48
See more estimates
10-Day MA$28.45
50-Day MA$31.16
200-Day MA$30.09
See more pivots

Arrowhead Pharmaceuticals Inc. Stock, NASDAQ:ARWR

177 East Colorado Boulevard, Suite 700, Pasadena, California 91105
United States of America
Phone: +1.626.304.3400
Number of Employees: 525

Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.